Purpose
The Medical Oncology Committee supports systemic treatments used in NRG trials through its subsidiary subcommittees, Pharmacy and Immunotherapy, and education during the NRG Semiannual meeting that includes a focused topical presentation as well as disease-site updates of the current state of the research. The Pharmacy subcommittee supports the NRG disease sites and protocol development with pharmacy-specific input including drug information and toxicity management. The Immunotherapy subcommittee evaluates NRG concepts that utilize immunotherapy for feasibility, safety, and potential translational objectives. Furthermore, the Immunotherapy subcommittee in conjunction with disease sites may propose concepts involving immunotherapy.
The Medical Oncology Committee hosts a comprehensive educational session twice yearly in conjunction with the NRG Semiannual Meeting; its subcommittees meet quarterly.